Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 known ✓ | P00918 | 6/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | GMNN | O75496 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | THPO | P40225 | 1/20 | 0.50 |
| ▸ | HBB | P68871 | 1/20 | 0.50 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | BBOX1 | O75936 | 2/20 | 0.41 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2384321 | 1.00 | ALDH1A1 (0.50) | ALDH1A1LMNATSHRGMNNTP53 | |
| SCHEMBL362292 | 1.00 | ALDH1A1 (0.50) | ALDH1A1LMNATSHRGMNNTP53 | |
| SCHEMBL2384964 | 1.00 | ALDH1A1 (0.50) | ALDH1A1LMNATSHRGMNNTP53 | |
| SCHEMBL2384441 | 1.00 | ALDH1A1 (0.50) | ALDH1A1LMNATSHRGMNNTP53 | |
| SCHEMBL4412723 | 1.00 | ALDH1A1 (0.50) | ALDH1A1LMNATSHRGMNNTP53 | |
| SCHEMBL10885084 | 1.00 | ALDH1A1 (0.50) | ALDH1A1LMNATSHRGMNNTP53 | |
| SCHEMBL29271944 | 1.00 | ALDH1A1 (0.50) | ALDH1A1LMNATSHRGMNNTP53 | |
| SCHEMBL2384744 | 1.00 | ALDH1A1 (0.50) | ALDH1A1LMNATSHRGMNNTP53 | |
| Bromide SCHEMBL31299733 | 0.97 | ALDH1A1 (0.48) | ALDH1A1LMNATSHRGMNNTP53 | |
| SCHEMBL193289 | 0.97 | ALDH1A1 (0.52) | ALDH1A1LMNATSHRGMNNTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8013049-B2 | Method for producing core-shell type highly liquid absorbent resin particles | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2011-09-06 | — | — | US | disclosed |
| EP-1669381-B1 | METHOD FOR PRODUCING CORE-SHELL HIGH LIQUID-ABSORBING RESIN PARTICLE | DAINIPPON INK & CHEMICALS (JP) | 2010-10-13 | — | — | EP | disclosed |
| US-20090197201-A1 | FLUOROSURFACTANTS | MERCK PATENT GESELLSCHAFT (DE) | 2009-08-06 | — | — | US | disclosed |
| US-20070276061-A1 | Method for Producing Core-Shell Type Highly Liquid Absorbent Resin Particles | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2007-11-29 | — | — | US | disclosed |
| EP-1669381-A1 | METHOD FOR PRODUCING CORE-SHELL HIGH LIQUID-ABSORBING RESIN PARTICLE | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2006-06-14 | — | — | EP | disclosed |
| US-4675439-A | CATALYTIC REDUCTION OF N-ACYL-B-PHENYLSERINE | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1987-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090197201-A1 | FLUOROSURFACTANTS | CBR3, SCO2, FPR3 | CA2 863/4885ALDH1A1 3874/4885LMNA 2391/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.